Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medivir Mulls Separation As Simeprevir Royalties Decline

Jun 15 2016

• By John Davis

chart

Related Content

Janssen gains FDA nod for HCV protease inhibitor Olysio

Nov 24 2013

Gilead Not Bullet-Proof After All: Harvoni US Sales Tumble More Than 50%

Apr 28 2016

Related Companies

Medivir AB

Johnson & Johnson

Gilead Sciences, Inc.

AbbVie Inc.

Additional Topics

Sweden Europe Business Strategies Infectious Diseases

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window